Novartis Investigative Site

Luxembourg 1210

0 studies enrolling now · 2 studies all time

What they study most

Cancer, Neoplasms, Breast, Renal Cell Carcinoma (RCC)

Studies at this site

• A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC) — Completed
• EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer — APPROVED_FOR_MARKETING